Background: Expression of matrix metalloproteinases (MMPs) by infi ltrating and intrinsic
INTRODUCTION
Anti-neutrophil cytoplasm antibodies (ANCA) directed against proteinase 3 and myeloperoxidase are the hallmark of a group of auto-immune small-vessel vasculitic disorders, such as Wegener's granulomatosis (WG), microscopic polyangiitis (MPA) and renal limited vasculitis [1, 2] . Many patients with these vasculitic disorders develop renal involvement with necrotizing crescentic glomerulonephritis, characterized by fi brinoid capillary necrosis and cellular crescents. Subsequently these cellular, infl ammatory crescents evolve and become acellular and fi brotic leading to permanent loss of functional glomerular volume. Th e development of crescents is the result of interaction between infi ltrating leukocytes, local proliferating cells and changes in the extracellular matrix.
Matrix metalloproteinases (MMPs), the main matrix degrading enzymes, have been implicated in both the infl ammatory and fi brotic phase of crescent formation and are upregulated during infl ammation and physiological remodelling processes [3] . MMP gene-expression and subsequent production as pro-enzymes is tightly regulated by various controlling mechanisms [4] . Th e extracellular activation of pro-MMPs is predominantly a two-step process with initial cleavage by a protease, followed by a fi nal cleavage, usually by another MMP [5, 6] . Specialised tissue inhibitors of matrix metalloproteinases (TIMPs) and various other molecules, including α 2 -macroglobulin, are able to inhibit activated MMPs [7] . During infl ammation activated MMPs degrade the extracellular matrix hence promoting trans-basement membrane migration of leukocytes and release of pro-infl ammatory products from the extra-cellular matrix. Th us MMPs are likely to have an important pathogenic role in the acute phase of human crescentic glomerulonephritis. To study whether MMPs refl ect renal infl ammation in active renal ANCA-associated vasculitis we determined intra-renal expression of MMPs, their activators and a specifi c MMP inhibitor, TIMP-1, and correlated this with histological and functional markers of renal disease.
PATIENTS AND METHODS

Renal biopsy specimens
Renal biopsy specimens were studied from 13 patients with active renal ANCA-associated vasculitis. Samples of normal kidney tissue from patients with renal cell carcinoma (n=4) were used as control specimens. Blinded to the clinical status and renal function of the patient at the time of biopsy, renal biopsies were evaluated by light microscopy. Normal, sclerosed, crescentic, and glomeruli with fi brinoid necrosis were counted. Results were expressed as percentage of the total number of glomeruli. Interstitial fi brosis, tubulointerstitial infl ammation, and atrophy were scored semi-quantitatively from 0 to 4 (0=no interstitial fi brosis/infl ammation/atrophy; 1=<10%; 2=10-25%; 3=25-50%; 4>50%). Age, ANCA-status, serum creatinine, proteinuria and CRP were recorded from all patients at the time of biopsy. Additionally, data on creatinine-clearance at biopsy, and 1, 3 and 12 months aft er renal biopsy were collected.
Immunohistochemistry
Frozen 4 mm sections were fi xed at room temperature (RT) for 10 minutes in 100% acetone and washed for 5 minutes in phophate buff ered saline (PBS, pH 7.4). Th e sections were incubated for one hour at RT with the primary antibody diluted in 1% Bovine Serum Albumin (BSA) in PBS (the source, specifi city and dilution of the primary antibodies are given in table 1). Next, the slides were rinsed with PBS for 5 minutes. Endogenous peroxidase activity was blocked by incubating the slides in 0.075% hydrogen peroxide/PBS for 30 minutes. Following three washes with PBS the slides were incubated for 30 minutes with peroxidase conjugated secondary antibodies (all from Dako, Glosstrup, Denmark; specifi c combinations are given in table 1), supplemented with 1% human AB serum. Th e sections were washed in PBS and peroxidase activity was developed in a freshly prepared solution of 3-amino-9-ethylcarbazol (AEC), containing 0.03% hydrogen peroxide for 10 minutes.
Counterstaining was performed using Mayer's hematoxylin. Control slides, which were incubated in PBS in the absence of the primary antibody, were consistently negative.
Positively stained cells in the glomeruli were manually counted, and interstitial staining was scored semi-quantitatively from 0-4 (0=no staining; 1=occasional positive cells in <10% of interstitium; 2=positive cells in 10-25% of interstitium; 3=positive cells in 25-50% of interstitium; 4=positive cells in >50% of interstitium).
Additional double-labelling experiments were performed on cryostat sections. Briefl y, aft er blocking of endogenous peroxidase, sections were incubated with primary antibodies, monoclonal mouse anti-human CD68, polyclonal rabbit anti-human MPO, and mouse anti-human α-smooth muscle actin (α-SMA) respectively. In contrast to CD14, which predominantly labels monocytes, CD68 is a pan-macrophage marker. Peroxidase conjugated goat anti-mouse IgG3, IgG2a (SBA, Birmingham, USA) or swine anti-rabbit (DAKO, Glosstrup, Denmark) antibodies were added and peroxidase activity was developed in diaminobendizine (DAB). Subsequently, monoclonal mouse anti-human MMP-2, monoclonal mouse anti-human MMP-9 or monoclonal mouse anti-human TIMP-1, respectively, were added. Th en, secondary FITC labelled goat anti-mouse IgG1 (Southern Biotechnical Associates) was added. Finally, sections were stained using Mayer's hematoxylin.
In all double-labelling experiments appropriate isotype controls were included, these were consistently negative.
Statistical Analysis
Th e non-parametric Mann-Whitney test was used to compare clinical and histological data between PR3-and MPO-ANCA positive patients. Using this test renal expression of MMPs, TIMP-1 and markers of neutrophil and monocyte infi ltration were compared. Correlations were tested using Spearman's correlation coeffi cient. Statistical signifi cance was defi ned as a two-sided p<0.05. Tubulo-interstitial infl ammation did not diff er between the two groups.
RESULTS
Clinical and histological characteristics
Immunolocalization of MMP-2, -3, -9 and TIMP-1 in normal and nephritic glomeruli
Immunohistochemical staining in renal biopsies of patients with ANCA-associated glomerulonephritis revealed MMP-2 and -3 positive cells in cellular crescents. In addition, MMP-2 and -3 were detected in interstitial, glomerular and periglomerular cells (fi gure 1). but not macrophages, produced MMP-9 in various glomerulonephritides [8] . In addition, an essential step in the activation of MMPs, which are secreted as inactive proenzymes, is the cleavage by proteases derived from activated infl ammatory cells, especially neutrophils and monocytes. In experimental glomerulonephritis increased expression of
MMPs is associated with disease activity and infi ltration by infl ammatory cells. Recently, gene expression of MMP-2 and the membrane bound MT1-MMP, which is an important activator of MMPs, was shown to correlate in diff erent stages with infl ammation and renal damage in a longitudinal murine anti-GBM glomerulonephritis model [11] . Moreover, in another model treatment with an MMP-inhibitor targeting elevated levels of MMP-2 and MMP-9 expression in anti-Th y1.1 nephritis diminished histological damage and proteinuria [12] . However, in an accelerated model of anti-GBM nephritis MMP-9-defi cient mice showed more severe disease than control mice [13] . Th is suggests that MMP-9 not only causes glomerular damage, but might also protect glomeruli against injury, or promote glomerular recovery, aft er initial damage.
In human renal disease increased glomerular expression of MMP-9, but not of MMP-2, has been reported in IgA nephropathy, mesangial proliferative glomerulonephritis and lupus nephritis [8] . In addition, elevated plasma levels of MMP-2, MMP-3, MMP-9 and of TIMP-1 have been found in some of these diseases, while elevated urinary levels of MMP-2 and MMP-9 have been found in diabetic nephropathy [14] [15] [16] . In human rheumatoid arthritis elevated plasma levels of diff erent MMPs, most oft en MMP-3, have been found and correlated with disease activity [17] . Data on expression of MMPs and TIMP-1 in human crescentic glomerulonephritis have, to our knowledge, not been published. As our study involved only a limited number of patients, all with active glomerulonephritis at the time of renal biopsy, but none with previous, but currently inactive, renal disease we can not be certain that expression is not increased in the latter situation. However, expression of MMPs and TIMP-1 clearly co-localised with histological markers of active glomerulonephritis, i.e.
in crescentic glomeruli and within the tubulo-interstitial infi ltrates, while normal or sclerotic glomeruli were negative.
As has been suggested by others based on morphological data, our data, despite the limited number of biopsies, do suggest a diff erence in infl ammation according to ANCA antigenic specifi city [18] . In line with these morphological data, higher expression of infl ammation associated proteins in PR3-as compared to MPO-ANCA associated glomerulonephritis was found, although only for glomerular neutrophil elastase and MMP-9 this diff erence reached statistical signifi cance. Since our data suggest that MMPs and TIMP-1 expression is limited to active lesions of ANCA-associated glomerulonephritis and may refl ect infl ammatory activity, determination of plasma or urinary levels may be of potential value in assessing renal disease activity in these diseases and should be studied. Whether expression of MMPs or TIMPs in the acute or recovery stage of active ANCA-associated glomerulonephritis or other forms of glomerulonephritis also may have prognostic signifi cance on long term follow up has to be studied. Given the important role of TGF-β, and probably other pro-fi brotic cytokines such as CTGF in regulating expression and activation of MMPs and TIMPs, longitudinal assessment may be of value in predicting long term outcome in glomerulonephritis and other progressive renal diseases. Increased serum and urinary levels of TIMP-1 and the matrix protein tenascin have been described in patients with renal function impairment due to diff erent diseases, but have not been correlated to renal infl ammation and fi brosis or changes of renal function during follow up [19] . Likewise, cross-sectional data in patients with a kidney transplant have correlated renal TIMP-1 mRNA expression with interstitial fi brosis 6 months post transplant, but not to serum and urinary levels of TIMP-1 or renal function during follow up [8, 20] .
In conclusion, increased renal MMP-2, -3, -9 and TIMP-1 expression refl ected the infl ammatory process in ANCA-associated glomerulonephritis, in particular MMP-9 expression correlated with active glomerular lesions and tubulo-interstitial infl ammation.
Establishing a link between the increased infl ammation related renal expression and elevated serum or urinary levels of MMPs and TIMP-1 will be a fi rst step required to test whether monitoring of MMP and TIMP-1 levels has potential value as non-invasive marker of renal disease activity in ANCA-associated and other forms of glomerulonephritis.
